<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30916131</article-id><article-id pub-id-type="pmc">6436788</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0069</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Prosthesis-Patient Mismatch Negatively Affects Outcomes after Mitral
Valve Replacement: Meta-Analysis of 10,239 Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5356-2996</contrib-id><name><surname>S&#x000e1;</surname><given-names>Michel Pompeu Barros Oliveira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Cavalcanti</surname><given-names>Luiz Rafael Pereira</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Rayol</surname><given-names>S&#x000e9;rgio da Costa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Diniz</surname><given-names>Roberto Gouvea Silva</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Menezes</surname><given-names>Alexandre Motta</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Clavel</surname><given-names>Marie-Annick</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>DVM, PhD, FAHA</role></contrib><contrib contrib-type="author"><name><surname>Pibarot</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>DVM, PhD, FAHA, FACC, FESC, FASE</role></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Ricardo Carvalho</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD, MSc, PhD, ChM, AATS</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Cardiovascular Surgery at the Pronto Socorro
Cardiol&#x000f3;gico de Pernambuco (PROCAPE), Recife, PE, Brazil.</aff><aff id="aff2">
<label>2</label> Universidade de Pernambuco (UPE), Recife, PE, Brazil.</aff><aff id="aff3">
<label>3</label> Nucleus of Postgraduate Studies and Research in Health Sciences at
Faculdade de Ci&#x000ea;ncias M&#x000e9;dicas and Instituto de Ci&#x000ea;ncias
Biol&#x000f3;gicas (FCM/ICB), Recife, PE, Brazil.</aff><aff id="aff4">
<label>4</label> Institut Universitaire de Cardiologie et de Pneumologie du
Qu&#x000e9;bec, Canada.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Michel Pompeu Barros Oliveira
S&#x000e1;</bold>, http://orcid.org/0000-0001-5356-2996, Pronto-Socorro
Cardiol&#x000f3;gico de Pernambuco (PROCAPE), Rua dos Palmares, S/N - Santo Amaro
- Recife, PE, Brazil - Zip code: 74970-240. E-mail:
<email>michel_pompeu@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2019</year></pub-date><volume>34</volume><issue>2</issue><fpage>203</fpage><lpage>212</lpage><history><date date-type="received"><day>21</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>21</day><month>2</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>This study sought to evaluate the impact of prosthesis-patient mismatch on
the risk of perioperative and long-term mortality after mitral valve
replacement.</p></sec><sec><title>Methods</title><p>Databases were researched for studies published until December 2018. Main
outcomes of interest were perioperative and 10-year mortality and
echocardiographic parameters.</p></sec><sec><title>Results</title><p>The research yielded 2,985 studies for inclusion. Of these, 16 articles were
analyzed, and their data extracted. The total number of patients included
was 10,239, who underwent mitral valve replacement. The incidence of
prosthesis-patient mismatch after mitral valve replacement was 53.7% (5,499
with prosthesis-patient mismatch and 4,740 without prosthesis-patient
mismatch). Perioperative (OR 1.519; 95%CI 1.194-1.931,
<italic>P</italic>&#x0003c;0.001) and 10-year (OR 1.515; 95%CI 1.280-1.795,
<italic>P</italic>&#x0003c;0.001) mortality was increased in patients with
prosthesis-patient mismatch. Patients with prosthesis-patient mismatch after
mitral valve replacement had higher systolic pulmonary artery pressure and
transprosthethic gradient and lower indexed effective orifice area and left
ventricle ejection fraction.</p></sec><sec><title>Conclusion</title><p>Prosthesis-patient mismatch increases perioperative and long-term mortality.
Prosthesis-patient mismatch is also associated with pulmonary hypertension
and depressed left ventricle systolic function. The findings of this study
support the implementation of surgical strategies to prevent
prosthesis-patient mismatch in order to decrease mortality rates.</p></sec></abstract><kwd-group><kwd>Mitral Valve/Surgery</kwd><kwd>Heart Valve Prosthesis</kwd><kwd>Meta-Analysis</kwd><kwd>Prosthesis-Patient Mismatch</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">iEOA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Indexed effective
orifice area</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricle ejection
fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MVR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mitral valve
replacement</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= <italic>Odds
Ratio</italic></td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PPM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Prosthesis-patient
mismatch</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PRISMA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Preferred Reporting
Items for Systematic Reviews and Meta-Analyses</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><sec><title>Rationale</title><p>Recent meta-analyses including several studies with thousands of patients have
been published in order to evaluate whether prosthesis-patient mismatch (PPM) is
a risk factor for short- and long-term mortality after aortic valve replacement,
showing an increase in all-cause mortality<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>Since we do not see the same amount of publications when it comes to PPM after
mitral valve replacement (MVR), we decided to carry out a new systematic review
with meta-analysis in order to evaluate the impact of PPM after MVR.</p></sec><sec><title>Objectives</title><p>We aimed to investigate whether PPM increases the risk for death after MVR. This
analysis was planned in accordance with current guidelines for performing
comprehensive systematic reviews and meta-analysis, including the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> guidelines. We pre-specified
our analytical plan and registered the study protocol with PROSPERO, the
international prospective register of systematic reviews (CRD42018089901).</p></sec></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Eligibility Criteria</title><p>With the PICOS (Population, Intervention, Comparison, Outcome and Study design)
strategy, studies were considered if: 1) the population comprised patients who
underwent surgical MVR; 2) there was a group of patients who developed PPM (with
an indexed effective orifice area (iEOA) - threshold of 1.20
cm<sup>2</sup>/m<sup>2</sup>) after MVR; 3) there was a control group of
patients with no PPM; 4) outcomes included any of the following: perioperative
or 10-year mortality rates as primary outcomes OR mean transprothetic gradient
(mmHg), mean systolic pulmonary artery pressure (mmHg) and left ventricle
ejection fraction (LVEF - %) as secondary outcomes; 5) studies were
retrospective, prospective, randomized or non-randomized.</p></sec><sec><title>Information Sources</title><p>The following databases were used (until December 2018): MEDLINE; EMBASE;
CENTRAL/CCTR (Cochrane Controlled Trials Register); ClinicalTrials.gov; SciELO
(Scientific Electronic Library Online); LILACS (Literatura Latino Americana em
Ci&#x000ea;ncias da Sa&#x000fa;de); Google Scholar; and reference lists of
relevant articles.</p></sec><sec><title>Search</title><p>We conducted the search with the following terms: "mismatch OR PPM OR
patient-prosthesis mismatch OR prosthesis-patient mismatch" and "MVR OR mitral
valve replacement" OR "mitral valve prosthesis" OR "mitral valve implantation"
OR "prosthetic mitral valve" OR "mitral prosthesis".</p></sec><sec><title>Study Selection</title><p>The following steps were taken: 1) identification of titles of records through
databases searching; 2) removal of duplicates; 3) screening and selection of
abstracts; 4) assessment for eligibility through full-text articles; and 5)
final inclusion in study. One reviewer followed steps 1 to 3. Two independent
reviewers followed step 4 and selected studies. Inclusion or exclusion of
studies was decided unanimously. When there was disagreement, a third reviewer
made the final decision.</p></sec><sec><title>Data Items</title><p>The crude endpoints were perioperative mortality, 10-year mortality, mean
transprothetic gradient, mean systolic pulmonary artery pressure and LVEF.</p></sec><sec><title>Data Collection Process</title><p>Two independent reviewers extracted the data. When there was disagreement about
the data, a third reviewer checked them and made the final decision. From each
study, we extracted patient characteristics, study design, and outcomes. When
the data were not clearly available in the articles, we contacted the authors of
the original articles by email.</p></sec><sec><title>Summary Measures</title><p>The principal summary measures were <italic>odds ratio</italic> (OR) with 95%
Confidence interval (CI) and <italic>P</italic>-values (considered statistically
significant when <italic>P</italic>&#x0003c;0.05) for mortality and difference in
means for the other outcomes. The meta-analysis was completed with the software
Comprehensive Meta-Analysis (version 2, Biostat, Inc., Englewood, New
Jersey).</p></sec><sec><title>Synthesis of Results</title><p>Forest plots were generated for graphical presentations of clinical outcomes, and
we performed the I<sup>2</sup> test and &#x003c7;<sup>2</sup> test for the
assessment of heterogeneity across the studies<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Inter-study heterogeneity was explored using
the &#x003c7;<sup>2</sup> statistic, but the I<sup>2</sup>-value was calculated
to quantify the degree of heterogeneity across the studies that could not be
attributable to chance alone. When I<sup>2</sup> was more than 50%, significant
statistical heterogeneity was considered to be present. Each study was
summarized by the OR or difference in means depending on the outcome, whose
values were combined across the studies using a weighted DerSimonian-Laird
random effects model<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p></sec><sec><title>Risk of Bias Across Studies</title><p>To assess publication bias, a funnel plot was generated for each outcome,
statistically assessed by Begg and Mazumdar's test<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> and Egger's test<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p></sec><sec><title>Sensitivity Analysis</title><p>We also investigated the influence of each study on the overall effect - by
sequentially removing one study - in order to test the robustness of the main
results, so that we could verify whether any study had an excessive influence on
the overall results.</p><p>Furthermore, we analyzed the data as to the way the iEOA was measured (predicted
from EOA measured in vitro by the manufacturer; or predicted from published
normal reference values of EOA measured in vivo; or measured directly in each
patient by Doppler-echocardiography following MVR).</p></sec><sec><title>Meta-regression Analysis</title><p>Meta-regression analyses were performed to determine whether the effects of PPM
on mortality were modulated by pre-specified factors. Meta-regression graphs
describe the effect of PPM on the outcome (plotted as a log OR on the y-axis) as
a function of a given factor (plotted as a mean or proportion of that factor on
the x-axis). Meta-regression coefficients show the estimated increase in log OR
per unit increase in the covariate. Since log OR &#x0003e; 0 corresponds to OR &#x0003e; 1
and log OR &#x0003c; 0 corresponds to OR &#x0003c; 1, a negative coefficient would
indicate that as a given factor increases, the OR decreases.</p><p>The pre-determined modulating factors to be examined were male sex (%), female
sex (%), age (years), hypertension (%), diabetes (%), renal failure (%), smoking
(%), preoperative atrial fibrillation (%), bioprosthesis (%), mechanical valve
(%), concomitant procedures (%), previous cardiac surgery (%) and LVEF (%).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Study Selection</title><p>A total of 2,985 citations were identified, of which 34 studies were potentially
relevant and retrieved as full-text. Sixteen publications<sup>[<xref rid="r8" ref-type="bibr">8</xref>-<xref rid="r23" ref-type="bibr">23</xref>]</sup> fulfilled our eligibility criteria. Interobserver
reliability of study relevance was excellent (Kappa=0.85). Agreement for
decisions related to study validity was very good (Kappa=0.85). The search
strategy can be seen in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flow diagram of studies included in data search.</p><p>CCTR=Cochrane Controlled Trials Register; LILACS=Literatura Latino
Americana em Ci&#x000ea;ncias da Sa&#x000fa;de; SciELO=Scientific
Electronic Library Online</p></caption><graphic xlink:href="rbccv-34-02-0203-g01"/></fig>
</p></sec><sec><title>Study Characteristics</title><p>A total of 10,239 patients (with PPM: 5,499 patients; without PPM: 4,740
patients) were included from studies published from 2007 to 2018. The incidence
of PPM after MVR was 53.7%, varying from 17.7% to 85.8%. The studies consisted
of patients whose mean age ranged from 38.5 to 67.4 years. There were studies
mostly from Asia, North America and Europe; only one from Latin America. All the
publications were retrospective cohort studies, and 68.8% had some multivariate
adjustment for possible confounders. Other characteristics are described
elsewhere.</p><p>Synthesis of Results</p><p>The OR for perioperative mortality in the PPM group compared with the no PPM
group in each study is reported in <xref ref-type="fig" rid="f2">Figure
2A</xref>. There was evidence of low statistical heterogeneity of treatment
effect among the studies for perioperative mortality. The overall OR (95%CI) of
perioperative mortality showed a statistically significant difference between
the groups, with higher risk in the PPM group (random effect model: OR 1.519;
95%CI 1.194-1.931, <italic>P</italic>&#x0003c;0.001).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Odds ratio and conclusions plot of perioperative and 10-year
mortality.This figure shows the summary effect of moderate/severe
PPM on perioperative mortality.</p><p>CI=confidence interval; PPM=patient-prosthesis mismatch</p></caption><graphic xlink:href="rbccv-34-02-0203-g02"/></fig>
</p><p>The OR for 10-year mortality in the PPM group compared with the no PPM group in
each study is reported in <xref ref-type="fig" rid="f2">Figure 2B</xref>. There
was evidence of moderate statistical heterogeneity of treatment effect among the
studies for 10-year mortality. The overall OR (95%CI) of 10-year mortality
showed a statistically significant difference between the groups, with higher
risk in the PPM group (random effect model: OR 1.515; 95%CI 1.280-1.795,
<italic>P</italic>&#x0003c;0.001).</p><p>The differences in mean values of iEOA in PPM group compared with the no PPM
group in each study are reported in <xref ref-type="fig" rid="f3">Figure
3A</xref>. There was evidence for important heterogeneity of treatment
effect among the studies for difference in means of iEOA. The overall difference
in means was statistically significantly lower in the PPM group (random effect
model: -0.376 cm<sup>2</sup>/m<sup>2</sup>; 95%CI -0.478 to -0.275;
<italic>P</italic>&#x0003c;0.001).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Odds ratio and conclusions plot of echocardiographic variables. This
figure shows the summary difference in means for the outcomes.</p><p>CI=confidence interval; iEOA=indexed effective orifice area;
LVEF=left ventricle ejection fraction; PPM=patient-prosthesis
mismatch</p></caption><graphic xlink:href="rbccv-34-02-0203-g03"/></fig>
</p><p>The differences in mean values of transprosthetic gradient in PPM group compared
with the no PPM group in each study are reported in <xref ref-type="fig" rid="f3">Figure 3B</xref>. There was evidence for important heterogeneity of
treatment effect among the studies for difference in means of transprosthetic
gradient. The overall difference in means was statistically significantly higher
in the PPM group (random effect model: 2.043 mmHg; 95%CI 1.015 to 3.072;
<italic>P</italic>&#x0003c;0.001).</p><p>The differences in mean values of systolic pulmonary artery pressure in PPM group
compared with the no PPM group in each study are reported in <xref ref-type="fig" rid="f3">Figure 3C</xref>. There was evidence for important
heterogeneity of treatment effect among the studies for difference in means of
this outcome. The overall difference in means was statistically significantly
higher in the PPM group (random effect model: 8.704 mmHg; 95%CI 5.877 to 11.531;
<italic>P</italic>&#x0003c;0.001).</p><p>The differences in mean values of LVEF in PPM group compared with the no PPM
group in each study are reported in <xref ref-type="fig" rid="f3">Figure
3D</xref>. There was evidence for moderate heterogeneity of treatment effect
among the studies for difference in means of LVEF. The overall difference in
means was statistically significantly lower in the PPM group (random effect
model: -1.933%; 95%CI -3.784 to -0.083; <italic>P</italic>=0.041).</p><p>Risk of Bias Across Studies</p><p>Funnel plot analysis (<xref ref-type="fig" rid="f4">Figure 4</xref>) disclosed no
asymmetry around the axis for the outcomes, which means that we have low risk of
publication bias related to these outcomes.</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Publication bias. Funnel plot analysis of the outcomes perioperative
and 10-year mortality.</p></caption><graphic xlink:href="rbccv-34-02-0203-g04"/></fig>
</p></sec><sec><title>Sensitivity Analysis</title><p>Sensitivity analyses performed by removing each single study from the
meta-analysis (in order to determine the influence of individual data sets on
the pooled ORs or difference in means) showed that none of the studies had a
particular impact on the summary results.</p><p>When we analyzed the data according to how the iEOA was measured in order to
define the presence of PPM (whether <italic>in vivo, in vitro</italic> or
measured by echocardiography), we found that the overall OR (95%CI) for 10-year
mortality showed a statistically significant difference with higher risk in the
"PPM" group only when the iEOA was measured by the referenced iEOA (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Sensitivity analysis. Funnel plot analysis of the outcomes for
measured and referenced iEOA.</p></caption><graphic xlink:href="rbccv-34-02-0203-g05"/></fig>
</p></sec><sec><title>Meta-Regression Analysis</title><p>None of the pre-determined factors (sex, age, hypertension, diabetes, renal
failure, smoking, preoperative atrial fibrillation, type of valve, concomitant
procedures, previous cardiac surgery, LVEF) showed any particular modulating
effect on the results.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><sec><title>Summary of Evidence</title><p>To the best of our knowledge, this is the largest meta-analysis of studies
performed to date that provides additional value by demonstrating that patients
with PPM have higher risk for mortality in comparison to those with no PPM after
MVR. We also observed that more than half of the patients leave the operation
room with significant PPM, having this aspect a negative impact not only on the
long term, but also already on the perioperative period. Patients with PPM also
showed higher systolic pulmonary artery pressure and transprosthethic
gradient.</p></sec><sec><title>Clinical Implications According to Geographical Localization</title><p>These results have important clinical implications given that PPM is a
potentially modifiable risk factor. Considering that we observed an incidence of
PPM after MVR higher than 50% that implies higher rates of mortality, it would
be no exaggeration to say that this problem has reached epidemic proportions and
surgeons would have to take measures to counter the risk of PPM after MVR in
order to decrease mortality.</p><p>We must highlight that not all the countries of the world can afford the
so-called "new generation" prostheses with larger effective orifice areas. In
the largest country of Latin America, Brazil, for example, more than 90% of the
patients are operated on at centers of the public health system, where the
patients cannot receive these new generation prostheses simply because they are
not available in the system due to their prices. Indeed, these new models of
prostheses are easily available in Europe and in the USA, but not within the
public health systems in Latin America (including Brazil), Africa and most part
of Asia, where surgeons have to work with other types of prostheses, with
"older" technology. Moreover, in Europe and in the USA, PPM is often diagnosed
in small, elderly women whereas in developing countries, surgeons mostly come
across younger patients who are part of the working age population who suffer
from rheumatic heart disease.</p></sec><sec><title>What might be the solution to this problem?</title><p>Although several procedures have been described for enlargement of the aortic
anulus, such as the Nicks, Manougian, and Konno procedures, there are very few
options for enlargement of the mitral anulus. This is because of the presence of
the circumflex coronary artery, membranous ventricular septum, the conduction
bundle and the aortic valve, which encircle the mitral anulus. Some surgeons
have performed supra-annular mitral valve replacement when the mitral anulus has
been inadequate to accept an adequate-sized mitral prosthesis. Supra-annular
mitral valve replacement involves insertion of the prosthesis entirely within
the left atrium, thereby creating a ventricularized portion of the left atrium.
Early results have been discouraging, with high mortality and the risk of left
atrial diastolic dysfunction and pulmonary vein stenosis<sup>[<xref rid="r24" ref-type="bibr">24</xref>-<xref rid="r26" ref-type="bibr">26</xref>]</sup>, although other reports have shown good
results<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>.
Furthermore, supra-annular MVR does not protect against leaflet entrapment or
valve thrombosis, which occurred in 13% of the patients with supra-annular MVR
reported by Kanter et al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>.</p><p>Jonas et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup> described a
surgical technique used in the context of pediatric cardiac surgery that might
well be applied in the context of adult cardiac surgery in order to enlarge the
mitral annulus. Myers et al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> studied 205 mitral valve replacement procedures carried
out between 1990 and 2012, and mitral annulus enlargement techniques were
analyzed, which included intraoperative balloon dilation of the annulus under
direct vision, radial annular incisions, and patch augmentation of the
aorto-mitral continuity. By using these techniques, it was possible to enlarge
the annulus. However, the authors also underscored that there is a nontrivial
risk of heart block with annulus upsizing, which deserves further study.</p></sec><sec><title>Sources of Heterogeneity</title><p>The statistical heterogeneity in the analyses of the continuous variables might
be related to various sources - for example, to the type of prosthesis
(bioprosthetic or mechanical valve). The type of valve could be a confounding
factor, as mechanical valves are implanted more often in younger patients, who
generally have a more active lifestyle and faster metabolism. Just a word of
caution: most of the studies were composed of a mixed pool of patients
(receiving biological or mechanical valves) and we were not able to break down
the data in those studies, otherwise we could have gone deeper in the
analysis.</p><p>Another important source of heterogeneity might be the definition of PPM applied
in the studies. Indeed, when we carried out subgroup analyses according to the
method used to define PPM, we observed that the use of predicted (measured in
vitro by the manufacturers or <italic>in vivo</italic> from published normal
reference values) or measured iEOA had different impacts on the pooled results
for 10-year mortality rates.</p></sec><sec><title>Risk of Bias and Limitations of the Present Study</title><p>There are inherent limitations with meta-analyses, including the use of
cumulative data from summary estimates. Patient data were gathered from
published data, not from individual patient follow-up. Access to individual
patient data would have enabled us to conduct further subgroup analysis and
propensity analysis to account for differences between the treatment groups.
This meta-analysis included data from studies that reflect the "real world" but,
on the other hand, are less limited by publication bias, treatment bias,
confounders, and a certain tendency to overestimate treatment effects observed
in the observational studies, since patient selection alters outcome and, thus,
makes non-randomized studies less robust.</p><p>Moreover, considerable statitiscal heterogeneity was observed in some analyses,
but we used the random-effects model to counterbalance this aspect. We also
observed low risk of publication bias in the outcomes. We must remind the
readers of the fact that research with statistically significant results is more
likely to be submitted to medical journals and published than work with null or
non-significant results, being the former also more likely to appear more
prominently in English, in higher impact journals. All of the aforementioned
aspects lead to the appearance of publication biases, but, in this case, we
cannot state that the impact of PPM on mortality rates observed in our study is
solely due to bias.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This meta-analysis found that PPM is associated with a significant increase in
perioperative and long-term mortality rates after surgical MVR. Hence, a particular
effort should be made to prevent PPM, and especially, severe PPM, at the time of
MVR.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MPBOS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; agreement to be accountable for
all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LRPC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SCR</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AMM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PP</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAC</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RCL</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Department of Cardiovascular Surgery, Pronto
Socorro Cardiol&#x000f3;gico de Pernambuco (PROCAPE), Recife, PE, Brazil.</p></fn><fn fn-type="other"><p>Fast Track</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayan</surname><given-names>V</given-names></name><name><surname>Vignolo</surname><given-names>G</given-names></name><name><surname>Soca</surname><given-names>G</given-names></name><name><surname>Paganini</surname><given-names>JJ</given-names></name><name><surname>Brusich</surname><given-names>D</given-names></name><name><surname>Pibarot</surname><given-names>P</given-names></name></person-group><article-title>Predictors and outcomes of Prosthesis-Patient Mismatch After
Aortic Valve Replacement</article-title><source>JACC Cardiovasc Imaging</source><month>8</month><year>2016</year><volume>9</volume><issue>8</issue><fpage>924</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2015.10.026</pub-id><pub-id pub-id-type="pmid">27236530</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;</surname><given-names>MPBO</given-names></name><name><surname>de Carvalho</surname><given-names>MMB</given-names></name><name><surname>Sobral Filho</surname><given-names>DC</given-names></name><name><surname>Cavalcanti</surname><given-names>LRP</given-names></name><name><surname>Rayol</surname><given-names>SDC</given-names></name><name><surname>Diniz</surname><given-names>RGS</given-names></name><etal/></person-group><article-title>Surgical aortic valve replacement and patient-prosthesis
mismatch: a meta-analysis of 108 182 patients</article-title><source>Eur J Cardiothorac Surg</source><day>16</day><month>1</month><year>2019</year><pub-id pub-id-type="doi">10.1093/ejcts/ezy466</pub-id><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><collab>PRISMA Group</collab></person-group><article-title>Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement</article-title><source>PLoS Med</source><day>21</day><month>7</month><year>2009</year><volume>6</volume><issue>7</issue><elocation-id>e1000097</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><day>06</day><month>9</month><year>2003</year><volume>327</volume><issue>7414</issue><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerSimonian</surname><given-names>R</given-names></name><name><surname>Kacker</surname><given-names>R</given-names></name></person-group><article-title>Random-effects model for meta-analysis of clinical trials: an
update</article-title><source>Contemp Clin Trials</source><month>2</month><year>2007</year><volume>28</volume><issue>2</issue><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">16807131</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begg</surname><given-names>CB</given-names></name><name><surname>Mazumdar</surname><given-names>M</given-names></name></person-group><article-title>Operating characteristics of a rank correlation test for
publication bias</article-title><source>Biometrics</source><month>12</month><year>1994</year><volume>50</volume><issue>4</issue><fpage>1088</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">7786990</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name></person-group><article-title>Bias in meta-analysis detected by a simple, graphical
test</article-title><source>BMJ</source><day>13</day><month>9</month><year>1997</year><volume>315</volume><issue>7109</issue><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">9310563</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akuffu</surname><given-names>AM</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name></person-group><article-title>Prosthesis-patient mismatch after mitral valve replacement: a
single-centered retrospective analysis in East China</article-title><source>J Cardiothorac Surg</source><day>03</day><month>10</month><year>2018</year><volume>13</volume><issue>1</issue><fpage>100</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1186/s13019-018-0788-4</pub-id><pub-id pub-id-type="pmid">30285794</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Chang</surname><given-names>BC</given-names></name><name><surname>Youn</surname><given-names>YN</given-names></name><name><surname>Joo</surname><given-names>HC</given-names></name><name><surname>Yoo</surname><given-names>KJ</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name></person-group><article-title>Impact of prosthesis-patient mismatch after mitral valve
replacement in rheumatic population: Does mitral position prosthesis-patient
mismatch really exist?</article-title><source>J Cardiothorac Surg</source><day>10</day><month>10</month><year>2017</year><volume>12</volume><issue>1</issue><fpage>88</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1186/s13019-017-0653-x</pub-id><pub-id pub-id-type="pmid">29017586</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammannaya</surname><given-names>GKK</given-names></name><name><surname>Mishra</surname><given-names>P</given-names></name><name><surname>Khandekar</surname><given-names>JV</given-names></name><name><surname>Mohapatra</surname><given-names>CKR</given-names></name><name><surname>Seth</surname><given-names>HS</given-names></name><name><surname>Raut</surname><given-names>C</given-names></name><name><surname>Shah</surname><given-names>V</given-names></name><name><surname>Saini</surname><given-names>JS</given-names></name></person-group><article-title>Effect of prosthesis patient mismatch in mitral position on
pulmonary hypertension</article-title><source>Eur J Cardiothorac Surg</source><day>01</day><month>12</month><year>2017</year><volume>52</volume><issue>6</issue><fpage>1168</fpage><lpage>1174</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezx167</pub-id><pub-id pub-id-type="pmid">28591821</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>KB</given-names></name><name><surname>Ahn</surname><given-names>H</given-names></name></person-group><article-title>Patient-Prosthesis Mismatch After Mitral Valve Replacement: A
Propensity Score Analysis</article-title><source>Ann Thorac Surg</source><month>5</month><year>2016</year><volume>101</volume><issue>5</issue><fpage>1796</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2015.10.032</pub-id><pub-id pub-id-type="pmid">26794895</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borracci</surname><given-names>RA</given-names></name><name><surname>Rubio</surname><given-names>M</given-names></name><name><surname>Sestito</surname><given-names>ML</given-names></name><name><surname>Ingino</surname><given-names>CA</given-names></name><name><surname>Barrero</surname><given-names>C</given-names></name><name><surname>Rapallo</surname><given-names>CA</given-names></name></person-group><article-title>Incidence of prosthesis-patient mismatch in patients receiving
mitral Biocor&#x000ae; porcine prosthetic valves</article-title><source>Cardiol J</source><year>2016</year><volume>23</volume><issue>2</issue><fpage>178</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.5603/CJ.a2016.0011</pub-id><pub-id pub-id-type="pmid">26876065</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>IJ</given-names></name><name><surname>Hong</surname><given-names>GR</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>BC</given-names></name><name><surname>Shim</surname><given-names>CY</given-names></name><name><surname>Chang</surname><given-names>HJ</given-names></name><name><surname>Ha</surname><given-names>JW</given-names></name><name><surname>Chung</surname><given-names>N</given-names></name></person-group><article-title>Prosthesis-Patient Mismatch after Mitral Valve Replacement:
Comparison of Different Methods of Effective Orifice Area
Calculation</article-title><source>Yonsei Med J</source><month>3</month><year>2016</year><volume>57</volume><issue>2</issue><fpage>328</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.3349/ymj.2016.57.2.328</pub-id><pub-id pub-id-type="pmid">26847283</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Qiu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name></person-group><article-title>Star GK Bileaflet Mechanical Valve Prosthesis-Patient Mismatch
after Mitral Valve Replacement: A Chinese Multicenter Clinical
Study</article-title><source>Med Sci Monit</source><day>27</day><month>8</month><year>2015</year><volume>21</volume><fpage>2542</fpage><lpage>2546</lpage><pub-id pub-id-type="doi">10.12659/MSM.894044</pub-id><pub-id pub-id-type="pmid">26313311</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Shimahara</surname><given-names>Y</given-names></name><name><surname>Hata</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>J</given-names></name></person-group><article-title>Impact of prosthesis-patient mismatch on late recurrence of
atrial fibrillation after cryomaze procedure with mitral valve
replacement</article-title><source>Circ J</source><year>2014</year><volume>78</volume><issue>8</issue><fpage>1908</fpage><lpage>1914</lpage><pub-id pub-id-type="pmid">24998192</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeloni</surname><given-names>E</given-names></name><name><surname>Melina</surname><given-names>G</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><name><surname>Roscitano</surname><given-names>A</given-names></name><name><surname>Refice</surname><given-names>S</given-names></name><name><surname>Quarto</surname><given-names>C</given-names></name><name><surname>Comito</surname><given-names>C</given-names></name><name><surname>Pibarot</surname><given-names>P</given-names></name><name><surname>Sinatra</surname><given-names>R</given-names></name></person-group><article-title>Impact of prosthesis-patient mismatch on tricuspid valve
regurgitation and pulmonary hypertension following mitral valve
replacement</article-title><source>Int J Cardiol</source><day>09</day><month>10</month><year>2013</year><volume>168</volume><issue>4</issue><fpage>4150</fpage><lpage>4154</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2013.07.116</pub-id><pub-id pub-id-type="pmid">23931967</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>WY</given-names></name><name><surname>Yap</surname><given-names>CH</given-names></name><name><surname>Hayward</surname><given-names>PA</given-names></name><name><surname>Dinh</surname><given-names>DT</given-names></name><name><surname>Reid</surname><given-names>CM</given-names></name><name><surname>Shardey</surname><given-names>GC</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name></person-group><article-title>Impact of prosthesis--patient mismatch after mitral valve
replacement: a multicenter analysis of early outcomes and mid-term
survival</article-title><source>Heart</source><month>7</month><year>2011</year><volume>97</volume><issue>13</issue><fpage>1074</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1136/hrt.2010.219576</pub-id><pub-id pub-id-type="pmid">21602523</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuura</surname><given-names>K</given-names></name><name><surname>Mogi</surname><given-names>K</given-names></name><name><surname>Aoki</surname><given-names>C</given-names></name><name><surname>Takahara</surname><given-names>Y</given-names></name></person-group><article-title>Prosthesis-patient mismatch after mitral valve replacement
stratified by referred and measured effective valve area</article-title><source>Ann Thorac Cardiovasc Surg</source><year>2011</year><volume>17</volume><issue>2</issue><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">21597412</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name></person-group><article-title>Does patient-prosthesis mismatch affect long-term results after
mitral valve replacement?</article-title><source>Ann Thorac Cardiovasc Surg</source><month>6</month><year>2010</year><volume>16</volume><issue>3</issue><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">20930676</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>A</given-names></name><name><surname>Lawton</surname><given-names>JS</given-names></name><name><surname>Maniar</surname><given-names>HS</given-names></name><name><surname>Pasque</surname><given-names>MK</given-names></name><name><surname>Damiano Jr</surname><given-names>RJ</given-names></name><name><surname>Moon</surname><given-names>MR</given-names></name></person-group><article-title>Factors affecting survival after mitral valve replacement in
patients with prosthesis-patient mismatch</article-title><source>Ann Thorac Surg</source><month>10</month><year>2010</year><volume>90</volume><issue>4</issue><fpage>1202</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2010.05.018</pub-id><pub-id pub-id-type="pmid">20868815</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamieson</surname><given-names>WR</given-names></name><name><surname>Germann</surname><given-names>E</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>F</given-names></name><name><surname>Cheung</surname><given-names>A</given-names></name><name><surname>MacNab</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Effect of prosthesis-patient mismatch on long-term survival with
mitral valve replacement: assessment to 15 years</article-title><source>Ann Thorac Surg</source><month>4</month><year>2009</year><volume>87</volume><issue>4</issue><fpage>1135</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2009.01.056</pub-id><pub-id pub-id-type="pmid">19324139</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magne</surname><given-names>J</given-names></name><name><surname>Mathieu</surname><given-names>P</given-names></name><name><surname>Dumesnil</surname><given-names>JG</given-names></name><name><surname>Tann&#x000e9;</surname><given-names>D</given-names></name><name><surname>Dagenais</surname><given-names>F</given-names></name><name><surname>Doyle</surname><given-names>D</given-names></name><etal/></person-group><article-title>Impact of prosthesis-patient mismatch on survival after mitral
valve replacement</article-title><source>Circulation</source><day>20</day><month>3</month><year>2007</year><volume>115</volume><issue>11</issue><fpage>1417</fpage><lpage>1425</lpage><pub-id pub-id-type="pmid">17339554</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>BK</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name><name><surname>Hendry</surname><given-names>P</given-names></name><name><surname>Ruel</surname><given-names>M</given-names></name><name><surname>Masters</surname><given-names>R</given-names></name><name><surname>Bedard</surname><given-names>P</given-names></name><etal/></person-group><article-title>The impact of patient-prosthesis mismatch on late outcomes after
mitral valve replacement</article-title><source>J Thorac Cardiovasc Surg</source><month>6</month><year>2007</year><volume>133</volume><issue>6</issue><fpage>1464</fpage><lpage>1473</lpage><pub-id pub-id-type="pmid">17532940</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>MS</given-names></name><name><surname>Clarke</surname><given-names>DR</given-names></name><name><surname>Campbell</surname><given-names>DN</given-names></name><name><surname>Madigan</surname><given-names>CK</given-names></name><name><surname>Wiggins Jr</surname><given-names>JW</given-names></name><name><surname>Wolfe</surname><given-names>RR</given-names></name></person-group><article-title>The St. Jude Medical cardiac valve in infants and children: role
of anticoagulant therapy</article-title><source>J Am Coll Cardiol</source><month>1</month><year>1987</year><volume>9</volume><issue>1</issue><fpage>235</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">3794103</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adatia</surname><given-names>I</given-names></name><name><surname>Moore</surname><given-names>PM</given-names></name><name><surname>Jonas</surname><given-names>RA</given-names></name><name><surname>Colan</surname><given-names>SD</given-names></name><name><surname>Lock</surname><given-names>JE</given-names></name><name><surname>Keane</surname><given-names>JF</given-names></name></person-group><article-title>Clinical course and hemodynamic observations after supraannular
mitral valve replacement in infants and children</article-title><source>J Am Coll Cardiol</source><month>4</month><year>1997</year><volume>29</volume><issue>5</issue><fpage>1089</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">9120164</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Doorn</surname><given-names>C</given-names></name><name><surname>Yates</surname><given-names>R</given-names></name><name><surname>Tsang</surname><given-names>V</given-names></name><name><surname>deLeval</surname><given-names>M</given-names></name><name><surname>Elliott</surname><given-names>M</given-names></name></person-group><article-title>Mitral valve replacement in children: mortality, morbidity, and
haemodynamic status up to medium term follow up</article-title><source>Heart</source><month>12</month><year>2000</year><volume>84</volume><issue>6</issue><fpage>636</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">11083744</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanter</surname><given-names>KR</given-names></name><name><surname>Forbess</surname><given-names>JM</given-names></name><name><surname>Kirshbom</surname><given-names>PM</given-names></name></person-group><article-title>Redo mitral valve replacement in children</article-title><source>Ann Thorac Surg</source><month>8</month><year>2005</year><volume>80</volume><issue>2</issue><fpage>642</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">16039220</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>RA</given-names></name><name><surname>Keane</surname><given-names>JF</given-names></name><name><surname>Lock</surname><given-names>JE</given-names></name></person-group><article-title>Aortic valve-preserving procedure for enlargement of the left
ventricular outflow tract and mitral anulus</article-title><source>J Thorac Cardiovasc Surg</source><month>5</month><year>1998</year><volume>115</volume><issue>5</issue><fpage>1219</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">9605097</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>PO</given-names></name><name><surname>del Nido</surname><given-names>PJ</given-names></name><name><surname>McElhinney</surname><given-names>DB</given-names></name><name><surname>Khalpey</surname><given-names>Z</given-names></name><name><surname>Lock</surname><given-names>JE</given-names></name><name><surname>Baird</surname><given-names>CW</given-names></name></person-group><article-title>Annulus upsizing for mitral valve re-replacement in
children</article-title><source>J Thorac Cardiovasc Surg</source><month>8</month><year>2013</year><volume>146</volume><issue>2</issue><fpage>347</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2012.09.092</pub-id><pub-id pub-id-type="pmid">23473014</pub-id></element-citation></ref></ref-list></back></article>